IDSA on X: New in CID: A #dengue vaccine candidate was efficacious against symptomatic dengue in children and adolescents over 3 years post-vaccination across 8 endemic countries. 📄: #IDSAJournals #ClinInfectDis

Is new dengue vaccine efficacy data a relief or cause for concern

Opportunities for improved surveillance and control of dengue from

Invasive Haemophilus influenzae Type B Disease in Five

Frontiers Challenges in Dengue Vaccines Development: Pre

Four-year safety follow-up of the tetravalent dengue vaccine

The Impact of the Newly Licensed Dengue Vaccine in Endemic

Full article: Public health impact of pneumococcal conjugate

Frontiers Anti-dengue Vaccines: From Development to Clinical Trials

Impact of preexisting dengue immunity on Zika virus emergence in a

Dengue Vaccines: An Update

Is new dengue vaccine efficacy data a relief or cause for concern

Dengue and Zika virus infections are enhanced by live attenuated

Is new dengue vaccine efficacy data a relief or cause for concern